Nature cell biology · 2022
A single-cell atlas of non-haematopoietic cells in human lymph nodes and lymphoma reveals a landscape of stromal remodelling.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Abe Yoshiaki, Sakata-Yanagimoto Mamiko, Fujisawa Manabu, Miyoshi Hiroaki, Suehara Yasuhito, Hattori Keiichiro, Kusakabe Manabu, Sakamoto Tatsuhiro, Nishikii Hidekazu, Nguyen Tran B, Owada Yohei, Enomoto Tsuyoshi, Sawa Aya, Bando Hiroko, Yoshida Chikashi, Tabata Rikako, Terao Toshiki, Nakayama Masahiro, Ohshima Koichi, Usuki Kensuke, Oda Tatsuya, Matsue Kosei, Chiba Shigeru
Аннотация
The activities of non-haematopoietic cells (NHCs), including mesenchymal stromal cells and endothelial cells, in lymphomas are reported to underlie lymphomagenesis. However, our understanding of lymphoma NHCs has been hampered by unexplained NHC heterogeneity, even in normal human lymph nodes (LNs). Here we constructed a single-cell transcriptome atlas of more than 100,000 NHCs collected from 27 human samples, including LNs and various nodal lymphomas, and it revealed 30 distinct subclusters, including some that were previously unrecognized. Notably, this atlas was useful for comparative analyses with lymphoma NHCs, which revealed an unanticipated landscape of subcluster-specific changes in gene expression and interaction with malignant cells in follicular lymphoma NHCs. This facilitates our understanding of stromal remodelling in lymphoma and highlights potential clinical biomarkers. Our study largely updates NHC taxonomy in human LNs and analysis of disease status, and provides a rich resource and deeper insights into LN and lymphoma biology to advance lymphoma management and therapy.